BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yang T, Lau WY, Zhang H, Huang B, Lu JH, Wu MC. Grey zone in the Barcelona Clinic Liver Cancer Classification for hepatocellular carcinoma: Surgeons’ perspective. World J Gastroenterol 2015; 21(27): 8256-8261 [PMID: 26217077 DOI: 10.3748/wjg.v21.i27.8256]
URL: https://www.wjgnet.com/1948-5182/full/v21/i27/8256.htm
Number Citing Articles
1
A. Bauschke, A. Altendorf-Hofmann, C. Malessa, S. Schüle, J. Zanow, U. Settmacher. Which factors affect the long-term survival of patients with hepatocellular carcinoma UICC stage IV?Journal of Cancer Research and Clinical Oncology 2016; 142(12): 2593 doi: 10.1007/s00432-016-2260-y
2
Dan-Yun Ruan, Ze-Xiao Lin, Tian-Tian Wang, Hui Zhao, Dong-Hao Wu, Jie Chen, Min Dong, Qu Lin, Xiang-Yuan Wu, Yang Li. Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1Oncotarget 2016; 7(38): 61378 doi: 10.18632/oncotarget.11358
3
Jian-Hong Zhong, Guido Torzilli, Hao Xing, Chao Li, Jun Han, Lei Liang, Han Zhang, Shu-Yang Dai, Le-Qun Li, Feng Shen, Tian Yang. Controversies and evidence of hepatic resection for hepatocellular carcinomaBBA Clinical 2016; 6: 125 doi: 10.1016/j.bbacli.2016.10.001
4
Yongjiang Li, Yangxun Pan, Ximeng Lin, Jingyu Hou, Zili Hu, Li Xu, Zhongguo Zhou, Yaojun Zhang, Minshan Chen, Dandan Hu. Development and Validation of a Prognostic Score for Hepatocellular Carcinoma Patients in Immune Checkpoint Inhibitors Therapies: The Hepatocellular Carcinoma Modified Gustave Roussy Immune ScoreFrontiers in Pharmacology 2022; 12 doi: 10.3389/fphar.2021.819985
5
Tian Yang, Han Zhang, Jun Han, Meng-Chao Wu, Feng Shen. ReplyHepatology 2017; 65(5): 1773 doi: 10.1002/hep.28980
6
Marco Maccauro, Gianluca Aliberti, Carlo Chiesa, Carlo Spreafico. Clinical Applications of Nuclear Medicine Targeted Therapy2018; : 119 doi: 10.1007/978-3-319-63067-0_11
7
Sameh A Lashen, Mohamed M Elshafei, Fahmy H Hablass, Eman A Alsayed, Asmaa A Hassan. Liver stiffness as a predictor of hepatocellular carcinoma behavior in patients with hepatitis C related liver cirrhosisHepatobiliary & Pancreatic Diseases International 2020; 19(1): 22 doi: 10.1016/j.hbpd.2019.11.004
8
R. K. Tannus, S. R. Almeida-Carvalho, C. A. Loureiro-Matos, A. Miziara-Gonzalez, A. A. Salzedas-Netto, D. Szejnfeld, G. D'Ippolito, V. Pereira-Lanzoni, I. Souza-Silva, Ferruccio Bonino. Evaluation of survival of patients with hepatocellular carcinoma: A comparative analysis of prognostic systemsPLOS ONE 2018; 13(4): e0194922 doi: 10.1371/journal.pone.0194922
9
Monica M. Matsumoto, Samdeep Mouli, Priyali Saxena, Ahmed Gabr, Ahsun Riaz, Laura Kulik, Daniel Ganger, Haripriya Maddur, Justin Boike, Steven Flamm, Christopher Moore, Aparna Kalyan, Kush Desai, Bartley Thornburg, Michael Abecassis, Ryan Hickey, Juan Caicedo, Karen Grace, Robert J. Lewandowski, Riad Salem. Comparing Real World, Personalized, Multidisciplinary Tumor Board Recommendations with BCLC Algorithm: 321-Patient AnalysisCardioVascular and Interventional Radiology 2021; 44(7): 1070 doi: 10.1007/s00270-021-02810-8
10
Gill Al-Kadhimi. Hepatocellular carcinoma: management of a complex and challenging conditionGastrointestinal Nursing 2015; 13(Sup10): S20 doi: 10.12968/gasn.2015.13.Sup10.S20
11
Zhu-Jian Deng, Le Li, Yu-Xian Teng, Yu-Qi Zhang, Yu-Xin Zhang, Hao-Tian Liu, Jian-Li Huang, Zhen-Xiu Liu, Liang Ma, Jian-Hong Zhong. Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Current Status and ControversyJournal of Clinical and Translational Hepatology 2022; 10(1): 147 doi: 10.14218/JCTH.2021.00179
12
Wen-Tao Yan, Bing Quan, Jiong-Jie Yu, Tian Yang. Should we invariably follow the current guidelines to treat our HCC patients?Hepatobiliary & Pancreatic Diseases International 2019; 18(3): 301 doi: 10.1016/j.hbpd.2019.01.005